Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-038526
Filing Date
2017-06-08
Accepted
2017-06-08 16:11:41
Documents
2
Period of Report
2017-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2223
2 POA DOCUMENT poa.txt EX-24.3_729901 4034
  Complete submission text file 0001209191-17-038526.txt   7611
Mailing Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476
Business Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476 612-747-4423
BioAmber Inc. (Issuer) CIK: 0001534287 (see all company filings)

EIN.: 980601045 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals

Mailing Address C/O 1250 RENE-LEVESQUE WEST, SUITE 4310 MONTREAL A8 H3B4W8
Business Address
Settino Mario (Reporting) CIK: 0001708783 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35905 | Film No.: 17900342